FTCNX | TPAIX | FTCNX / TPAIX | |
Total Expense Ratio | 1.57 | 1.77 | 89% |
Annual Report Gross Expense Ratio | 1.57 | 1.77 | 89% |
Fund Existence | 18 years | 14 years | - |
Gain YTD | 14.110 | 18.737 | 75% |
Front Load | 4% | 6% | 64% |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 996M | 128M | 778% |
Annual Yield % from dividends | 0.68 | 0.85 | 80% |
Returns for 1 year | 12.77 | 43.75 | 29% |
Returns for 3 years | 15.39 | 21.97 | 70% |
Returns for 5 years | 61.70 | 82.31 | 75% |
Returns for 10 years | 54.87 | 140.68 | 39% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 19.76 | 0.18 | +0.91% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
OPP | 8.42 | 0.01 | +0.12% |
RiverNorth/DoubleLine Strategic Opportunity Fund | |||
DEED | 20.92 | -0.02 | -0.10% |
First Trust Securitized Plus ETF | |||
ILTB | 48.34 | -0.11 | -0.23% |
iShares Core 10+ Year USD Bond ETF | |||
UTG | 34.55 | -0.20 | -0.58% |
Reaves Utility Income Fund |